Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 2cureX 2CUREX Apr 25, 2025 0.59 +4.64   
 4C Group AB 4C Apr 25, 2025 14.60 -1.02   
 AAC Clyde Space AAC Apr 25, 2025 76.00 0.00   
 AAK AAK Apr 25, 2025 249.00 -2.28   
 ABAS Protect AB ABAS Apr 25, 2025 9.05 +0.56   
 ABB ABB Apr 25, 2025 505.00 +2.70   
 Abelco Investment Group ABIG Apr 25, 2025 0.00 0.00   
 Abera Bioscience ABERA Apr 25, 2025 8.00 -13.98   
 Absolent Air Care Group ABSO Apr 25, 2025 219.00 -1.35   
 Absolicon B ABSLB Apr 25, 2025 3.50 +0.29   
 AcadeMedia ACAD Apr 25, 2025 83.70 +4.23   
 Acarix ACARIX Apr 25, 2025 0.21 -1.84   
 Acast ACAST Apr 25, 2025 14.00 +4.32   
 Acconeer ACCON Apr 25, 2025 5.25 +2.54   
 Acenta Group PADEL Apr 25, 2025 9.58 0.00   
 AcouSort ACOU Apr 25, 2025 3.76 +0.27   
 Acrinova A ACRIA Apr 25, 2025 11.80 +4.42   
 Acrinova B ACRIB Apr 25, 2025 11.50 +5.70   
 ACROUD ACROUD Apr 25, 2025 0.14 +10.24   
 Actic Group ATIC Apr 25, 2025 17.40 +5.45   
 Active Biotech ACTI Apr 25, 2025 0.09 +1.16   
 AcuCort ACUC Apr 25, 2025 0.69 -4.16   
 Acuvi AB ACUVI Apr 25, 2025 14.36 -1.51   
 AddLife B ALIFB Apr 25, 2025 164.60 +4.64   
 Addnode Group B ANODB Apr 25, 2025 86.30 -13.87   
 Addtech B ADDTB Apr 25, 2025 313.40 +1.75   
 ADDvise Group A ADDVA Apr 25, 2025 3.37 -3.71   
 ADDvise Group B ADDVB Apr 25, 2025 1.32 +4.58   
 Adtraction ADTR Apr 25, 2025 32.50 +3.17   
 Advenica ADVE Apr 25, 2025 24.10 +10.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.